Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
absence, acknowledgement, Aldeyra, AMP, anesthesiologist, argued, Attorney, Bachelor, back, Banking, beneficiary, Boehringer, bound, cap, capping, caution, Ceiling, CHMP, clarity, clause, clock, Condensed, confirmatory, conserve, Cowen, CTA, currency, decentralized, diligence, disgorgement, dismissed, dissemination, donut, doubt, doubtful, Duke, Eastern, eighteen, endorsed, entirety, Experimental, explanatory, FDASIA, FDCA, FDORA, gap, GCP, geopolitical, GmbH, graduated, guarantee, harder, hole, hypermethylation, immigration, Immuron, inflation, Ingelheim, instability, instructed, intermediate, invoiced, IRA, IRB, justify, KeyBanc, labor, Lam, Latin, leaflet, Liangpunsakul, Lin, lipotoxicity, living, MAA, macroeconomic, maximum, MRP, necessitate, newly, noncurrent, nondeductible, nurse, obligatory, Papp, par, PDUFA, penalize, perception, placement, plc, political, portal, preliminarily, principle, proportionately, punishable, rarity, RBC, reauthorization, recession, reconsider, reexamining, refinance, regeneration, Renshaw, resumed, resumption, Rodman, Russia, Science, sector, seizure, sequester, Stifel, subtopic, supplement, terrorism, Timothy, tracing, twenty, Ukraine, unclear, unconstitutional, underlying, underway, uniform, unlimited, unnecessary, unpaid, unrest, verify, vouching, wage, waiver, warrant, weakening, Wharton, wrongfully
Removed:
AbbVie, accrual, accurately, Akero, Alabama, ALD, appointed, Arenberg, AstraZeneca, attracting, aware, broaden, cautiously, Clara, CLOUDTM, collaborated, Colorado, Concurrently, consummate, coordinate, Creation, defer, Denver, Discriminant, dispersed, Diversify, double, Eastman, eleven, Eli, Enanta, entry, exploitation, falk, fatty, Galectin, Galmed, Genentech, Genfit, geographically, GLP, hire, insured, Inventiva, Leavy, letter, lieu, Lilly, Madrigal, main, MedImmune, Michael, Mine, misappropriated, movement, NGM, nonalcoholic, Nordisk, Novo, ophthalmic, ophthalmology, originally, outbreak, passed, pause, PD, Pfizer, practical, promising, Protein, pursuing, Qualitative, Quantitative, reallocate, repeal, repealing, Santa, Santen, searchable, sensitivity, shift, slide, SucroMate, Supplementary, tolerable, transition, unavailable, undergraduate, vendor, vested, Viking, visit
Filing tables
Filing exhibits
Related press release
Associated DRRX transcripts
DRRX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
(1)
Registration Statements (Form S-8 Nos. 333-126990 and 333-98939) pertaining to the DURECT Corporation 2000 Directors’ Stock Option Plan,
(2)
Registration Statements (Form S-8 Nos. 333-166700, 333-161025, 333-152968, 333-124701, 333-86110, 333-47400 and 333-61224) pertaining to the DURECT Corporation 2000 Employee Stock Purchase Plan and the DURECT Corporation 2000 Stock Plan,
(3)
Registration Statements (Form S-8 Nos. 333-212842, 333-197980, 333-176113, 333-120405, 333-108390 and 333-226524) pertaining to the DURECT Corporation 2000 Stock Plan,
(4)
Registration Statements (Form S-8 No. 333-240326, 333-219832, 333-206084 and 333-170349) pertaining to the DURECT Corporation 2000 Employee Stock Purchase Plan, and
(5)
Registration Statements (Form S-3 Nos. 333-108398, 333-108396, 333-226518 and 333-258333) of DURECT Corporation, of our report dated March 8, 2023, with respect to the financial statements of DURECT Corporation included in this Annual Report (Form 10-K) of DURECT Corporation for the year ended December 31, 2022.
/s/ ERNST & YOUNG LLP |
|
|
|
San Francisco, California |
|
March 8, 2023 |
|